| Theme | Clinical practice guideline for CKD-MBD | |
|---|---|---|
| Title | Management of CKD-MBD during predialysis period | |
| Publish Date | 2012/10 | |
| Author | Hirotaka Komaba | Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine |
| [ Summary ] | Chronic kidney disease-mineral and bone disorder (CKD-MBD) develops early in the course of CKD and should be recognized as a progressive disorder beginning in the predialysis period. Recent epidemiologic data has demonstrated that the association between abnormalities in biochemical parameters of CKD-MBD and mortality and poor renal outcomes can be found in predialysis patients, suggesting that interventions during the predialysis period to control biochemical parameters improve patient-level outcomes. Under these circumstances, the Japanese Society for Dialysis Therapy released "Clinical Practice Guideline for CKD-MBD" in March 2012. It is hoped that this new guideline not only improves management of CKD-MBD in predialysis patients in Japan but also becomes a good chance to produce evidence for predialysis CKD-MBD from Japan. | |